WallStreetZenWallStreetZen

NASDAQ: AKAN
Akanda Corp Earnings & Revenue

AKAN past revenue growth

How has AKAN's revenue growth performed historically?
Company
3,466.29%
Industry
9.72%
Market
17.84%
AKAN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AKAN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AKAN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AKAN earnings and revenue history

Current Revenue
$3.9M
Current Earnings
-$14.9M
Current Profit Margin
-378.8%

AKAN Return on Equity

Current Company
-53.1%
Current Industry
11.8%
Current Market
25.7%
AKAN's Return on Equity (-53.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AKAN announces earnings.

AKAN Return on Assets

Current Company
-37.4%
Current Industry
3.7%
AKAN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AKAN Return on Capital Employed

Current Company
-60.66%
Current Industry
6.8%

AKAN vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AKAN$3.94M-$10.41M-$14.94M+3,466.29%N/A
SXTC$33.62k-$5.13M-$5.93M-51.98%N/A
RDHL$35.75M$13.30M$11.57M+33.85%N/A
CPHI$7.78M-$34.02k-$3.11M-9.66%N/A
LSDI$16.73k-$9.75M-$11.30MN/AN/A

Akanda Earnings & Revenue FAQ

What were AKAN's earnings last quarter?

Akanda (NASDAQ: AKAN) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Akanda earnings for the quarter were N/A. In the same quarter last year, Akanda's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Akanda stock.

What was AKAN's earnings growth in the past year?

As of Q1 2024, Akanda's earnings has grown year over year. Akanda's earnings in the past year totalled -$14.94 million.

What was AKAN's revenue last quarter?

Akanda (NASDAQ: AKAN) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Akanda's revenue was N/A.

What was AKAN's revenue growth in the past year?

As of Q1 2024, Akanda's revenue has grown 3,466.29% year over year. This is 3,456.57 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.72%. Akanda's revenue in the past year totalled $3.94 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.